"You decide and we provide."
Cart 0

FDA approves Mylan's biosimilar to Neulasta

reutersCOMPANYNEWS companyNews

June 4 (Reuters) - The U.S. Food And Drug Administration on Monday approved a drug from Mylan NV as the first biosimilar to Amgen's drug Neulasta to help reduce the risk of infection during cancer treatment.

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published